SCHEMBL7560616

SCHEMBL7560616

Cc1ccc(-c2ccc(C(=O)NC3C4CCN(CC4)C3C)o2)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 7/20 0.41
CHRNA7 P36544 7/20 0.41
CHRNA4 P43681 7/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
OPRM1 P35372 1/20 0.39
OPRD1 P41143 1/20 0.39
PDE4B Q07343 2/20 0.38
PDE4D Q08499 2/20 0.38
ACKR3 P25106 4/20 0.38
SLC9A1 P19634 1/20 0.38
S1PR4 O95977 1/20 0.38
KDM4E B2RXH2 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 2/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7061990 1.00 CHRNB2 (0.41) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7060716 0.91 PDE4B (0.47) PDE4BPDE4DACKR3SLC9A1GAA
SCHEMBL7058005 0.89 CHRNA7 (0.42) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7062872 0.88 CHRNB2 (0.44) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7062286 0.88 CHRNB2 (0.42) CHRNB2CHRNA7CHRNA4S1PR4MEN1
SCHEMBL7063432 0.87 RAB9A (0.52) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7063371 0.85 S1PR2 (0.50) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7061493 0.85 PDE7A (0.50) CHRNB2CHRNA7CHRNA4NPC1RAB9A
SCHEMBL7063300 0.83 CHRNB2 (0.50) CHRNB2CHRNA7CHRNA4
SCHEMBL7057847 0.83 CHRNB2 (0.51) CHRNB2CHRNA7CHRNA4NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed